Veru Inc. stock is up 28.26% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 24 December’s closed higher than November.
Veru Inc. focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company was formerly known as The Female Health Company.